RoundTable Healthcare Partners (RoundTable), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced a partnership and investment in Colorescience, Inc. (Colorescience).

Founded on a science-first approach to skincare and sun protection, Colorescience is known for its mineral-based, clinically validated products that deliver broad-spectrum protection with cosmetically elegant finishes. 

Mary Fisher, Chief Executive Officer of Colorescience, said,

“Since 2013, our team has built Colorescience into a trusted brand that delivers meaningful protection and performance for our customers. I want to sincerely thank our employees for their passion and dedication in helping us reach this exciting point in our evolution. We are thrilled to partner with RoundTable as we enter the next stage of growth, and we believe their values, culture, and operating expertise align closely with what makes Colorescience special.”

The company has built deep credibility among many dermatologists, plastic surgeons, aestheticians, and medical spas by combining rigorous clinical performance with products designed for daily use.

Colorescience serves customers through a diversified omni-channel model spanning the professional channel, direct-to-consumer, and leading e-commerce platforms. 

Currently, the company is well-positioned to further expand brand awareness, accelerate penetration across channels, and continue broadening its product portfolio while maintaining its clinical heritage.

Jawwad Akhtar, Partner at RoundTable, added, 

“Colorescience represents our ninth consumer healthcare platform investment, and further reinforces RoundTable’s commitment to partnering with management teams to build enduring, category-leading businesses with brands that are both expert-recommended and consumer-preferred. We believe our dedicated operating resources, channel expertise, and experience supporting practitioner-oriented brands position us well to help the Company accelerate growth and better serve its customers.”

Terms of the transaction were not disclosed.

Read Next

M&A Activity of 2026

Shareholders Approve Kimberly-Clark’s Acquisition of Kenvue